Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells: Experimental dermatology

Clinical and Experimental Dermatology

Volumn 35, Issue 5, 2010, Pages 531-536

  Shimoda, T ^a   Liang, Z ^a   Suzuki, H ^a   Kawana, S ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; ANXIOLYTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT; TANDOSPIRONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; FOOTSHOCK; MAST CELL DEGRANULATION; MENTAL STRESS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN CELL; SKIN INFLAMMATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; CELL DEGRANULATION; CHLORPROMAZINE; FEMALE; ISOINDOLES; MAST CELLS; MICE; MICE, INBRED C57BL; PIPERAZINES; PYRIDINES; PYRIMIDINES; STRESS, PSYCHOLOGICAL;

EID: 77953332775     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03650.x     Document Type: Article

References (25)

1. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory disease and the effect of acute stress. J Neuroimmunol 2004 146 : 1 12.
2. Singh LK, Pang X, Alexacos N et al. Acute immobilization stress triggers skin mast cell degranulation via corticotrophin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999 13 : 225 239.
3. Kaneko K, Kawana S, Arai K et al. Corticotrophin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats. Exp Dermatol 2003 12 : 47 52.
4. Kawana S, Liang Z, Nagano M, Susuki H. Role of substance P in stress-derived degranulation of dermal mast cell in mice. J Dermatol Sci 2006 42 : 47 54.
5. Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006 6 : 335 339.
6. Arck PC, Handjiski B, Peters EM et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003 162 : 803 814.
7. Thierry AM, Blanc G, Sobel A et al. Dopaminergic terminals in the rat cortex. Science 1973 182 : 499 501.
8. Roth RH, Tam SY, Ida Y et al. Stress and the mesocorticolimbic dopamine system. Ann N Y Acad Sci 1988 537 : 138 147.
9. Meller E, Bohmaker K. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 1994 271 : 1246 1252.
10. Shimizu H, Karai N, Hirose A et al. Interaction of SM-3997 with serotonin receptor in rat brain. Jpn J Pharmacol 1988 46 : 311 314.
11. Swanson LW, Sawchenko PE, Rivier J et al. Organization of ovine cort icotrophin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983 36 : 165 186.
12. Orth DN. Corticotrophin-releasing hormone in humans. Endocr Rev 1992 13 : 164 191.
13. Reul JM, Holsboer F. Corticotrophin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002 2 : 23 33.
14. Okuyama S, Chaki S, Kawashima N et al. Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotrophin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther 1999 289 : 926 935.
15. Kono M, Nagata S, Umemura S et al. In situ expression of corticotrophin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 2001 15 : 2297 2299.
16. Paus R, Theoharides TC, Arck PC. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006 27 : 32 9.
17. Theoharides TC, Donelan JM, Papadopoulou N et al. Mast cells as targets of corticotrophin-releasing factor and related peptides. Trends Pharmacol Sci 2004 25 : 563 568.
18. Cao J, Papadopoulou N, Kempuraj D et al. Human mast cells express corticotrophin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005 174 : 7665 7675.
19. Theoharides TC, Singh LK, Boucher M et al. Corticotrophin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 2006 139 : 403 413.
20. Donelan J, Boucher W, Papadopoulou N et al. Corticotrophin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 2006 16 : 7759 7764.
21. Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/ melatoninergic system: securing a place under the sun. FASEB J 2005 19 : 176 194.
22. Johnson HG, Miller MD. Inhibition of histamine release and ionophore-induced calcium flux in rat mast cells by lidocaine and chlorpromazine. Agents Actions 1979 9 : 239 243.
23. Linnet J, Jemec GB. Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Int J Dermatol 2001 40 : 632 636.
24. Toyoda M, Morohashi M. Morphological assessment of the effects of cyclosporine A on mast cell-nerve relationship in atopic dermatitis. Acta Derm Venereol 1998 78 : 321 325.
25. Chan J, Smoller BR, Raychauduri SP et al. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 1997 289 : 611 616.